186 related articles for article (PubMed ID: 37554060)
1. A comprehensive analysis of cell-autonomous and non-cell-autonomous regulation of myeloid leukemic cells: The prospect of developing novel niche-targeting therapies.
Pendse S; Chavan S; Kale V; Vaidya A
Cell Biol Int; 2023 Oct; 47(10):1667-1683. PubMed ID: 37554060
[TBL] [Abstract][Full Text] [Related]
2. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
[TBL] [Abstract][Full Text] [Related]
3. Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs.
Boyd AL; Campbell CJ; Hopkins CI; Fiebig-Comyn A; Russell J; Ulemek J; Foley R; Leber B; Xenocostas A; Collins TJ; Bhatia M
J Exp Med; 2014 Sep; 211(10):1925-35. PubMed ID: 25180064
[TBL] [Abstract][Full Text] [Related]
4. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches.
Hira VVV; Van Noorden CJF; Carraway HE; Maciejewski JP; Molenaar RJ
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):183-198. PubMed ID: 28363872
[TBL] [Abstract][Full Text] [Related]
5. Influence of Bone Marrow Microenvironment on Leukemic Stem Cells: Breaking Up an Intimate Relationship.
Agarwal P; Bhatia R
Adv Cancer Res; 2015; 127():227-52. PubMed ID: 26093902
[TBL] [Abstract][Full Text] [Related]
6. Regulation of hematopoietic and leukemia stem cells by regulatory T cells.
Riether C
Front Immunol; 2022; 13():1049301. PubMed ID: 36405718
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
8. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
Lefort S; Maguer-Satta V
Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-CXCL6 axis affects arteriolar niche remodeling in acute myeloid leukemia.
Li L; Man J; Zhao L
Exp Biol Med (Maywood); 2021 Jan; 246(1):84-96. PubMed ID: 33167688
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Malignant Myeloid Leukemia by Mesenchymal Stem Cells.
Tan Z; Kan C; Wong M; Sun M; Liu Y; Yang F; Wang S; Zheng H
Front Cell Dev Biol; 2022; 10():857045. PubMed ID: 35756991
[TBL] [Abstract][Full Text] [Related]
11. Targeting the bone marrow microenvironment in acute leukemia.
Karantanou C; Godavarthy PS; Krause DS
Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
[TBL] [Abstract][Full Text] [Related]
12. Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
Borella G; Da Ros A; Borile G; Porcù E; Tregnago C; Benetton M; Marchetti A; Bisio V; Montini B; Michielotto B; Cani A; Leszl A; Campodoni E; Sandri M; Montesi M; Bresolin S; Cairo S; Buldini B; Locatelli F; Pigazzi M
Blood; 2021 Aug; 138(7):557-570. PubMed ID: 34010415
[TBL] [Abstract][Full Text] [Related]
13. Functional Niche Competition Between Normal Hematopoietic Stem and Progenitor Cells and Myeloid Leukemia Cells.
Glait-Santar C; Desmond R; Feng X; Bat T; Chen J; Heuston E; Mizukawa B; Mulloy JC; Bodine DM; Larochelle A; Dunbar CE
Stem Cells; 2015 Dec; 33(12):3635-42. PubMed ID: 26388434
[TBL] [Abstract][Full Text] [Related]
14. Gap Junctions in the Bone Marrow Lympho-Hematopoietic Stem Cell Niche, Leukemia Progression, and Chemoresistance.
Singh AK; Cancelas JA
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991829
[No Abstract] [Full Text] [Related]
15. Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities.
O'Reilly E; Zeinabad HA; Szegezdi E
Blood Rev; 2021 Nov; 50():100850. PubMed ID: 34049731
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1β inhibits normal hematopoietic expansion and promotes acute myeloid leukemia progression via the bone marrow niche.
Wang Y; Sun X; Yuan S; Hou S; Guo T; Chu Y; Pang T; Luo HR; Yuan W; Wang X
Cytotherapy; 2020 Mar; 22(3):127-134. PubMed ID: 32024607
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic Mechanisms in Acute Myeloid Leukemia.
Chakraborty S; Park CY
Curr Treat Options Oncol; 2022 Nov; 23(11):1522-1534. PubMed ID: 36190670
[TBL] [Abstract][Full Text] [Related]
18. BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution.
Chai C; Sui K; Tang J; Yu H; Yang C; Zhang H; Li SC; Zhong JF; Wang Z; Zhang X
Theranostics; 2023; 13(12):3943-3963. PubMed ID: 37554265
[No Abstract] [Full Text] [Related]
19. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
20. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
Marchand T; Pinho S
Front Immunol; 2021; 12():775128. PubMed ID: 34721441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
